Cancer risks in Crohn disease patients

Area of Science:

• Gastroenterology
• Oncology
• Immunology

Background:

• Crohn disease (CD) patients exhibit elevated risks for bowel cancers and lymphoma.
• CD, an autoimmune condition, may predispose patients to a wider spectrum of malignancies.
• Investigating the full spectrum of cancer risks in CD patients is crucial for early detection and management.

Purpose of the Study:

• To investigate the association between Crohn disease and subsequent cancer development.
• To identify novel cancer sites with increased incidence in CD patients.
• To quantify the cancer risk in CD patients compared to the general population.

Main Methods:

• A CD research database was created using Swedish hospital discharge and cancer registries.
• Follow-up of 21,788 CD patients hospitalized between 1964-2004 identified 1,424 cancer cases.
• Standardized Incidence Ratios (SIRs) were calculated to compare cancer incidence in CD patients versus controls.

Main Results:

• CD patients showed increased risks for several additional cancers, including liver, pancreatic, lung, prostate, testicular, kidney, and skin (squamous cell) cancers.
• Novel sites like the liver, testis, and kidney exhibited SIRs greater than 2.0.
• Testicular cancer, specifically seminoma, had a significantly elevated SIR of 2.74.

Conclusions:

• This large-scale study identified numerous novel subsequent cancers in patients with Crohn disease.
• The findings suggest a broader predisposition to cancer in CD patients than previously recognized.
• Cancer risks in CD patients are influenced by age at first hospitalization, with varying effects depending on cancer type.